Case Number:

IPR2018-01670

Case Type:

IPR

Status:

Final Written Decision

Petitioner:

Mylan Pharmaceuticals Inc.

Patent Owner:

Sanofi-Aventis Deutshland GmbH

Tech Center:

3700

1. Filed: September 10, 2018 00:00

   Coverage

   1. April 06, 2020

      Mylan Gets PTAB To Nix Sanofi's Lantus Patent Claim

      Mylan has successfully persuaded the Patent Trial and Appeal Board that one claim of a Sanofi-Aventis patent covering the Lantus SoloStar disposable insulin injection pen is invalid as obvious.

   1 other articles on this case. View all »

   ---

   Stay ahead of the curve

   In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

   
   

   • Search PTAB cases and full-text documents.
   • Download filings with the U.S. Patent & Trademark Office’s Patent Trial & Appeal Board.
   • Set up alerts on new cases, follow ongoing cases, track new decisions and so much more!

   TRY LAW360 FREE FOR SEVEN DAYS

   View the PTAB case documents

   Already a subscriber? Click here to login